naion semaglutide news & Vision Loss: What the Latest Research Says 👁️💉 A new multinational study analyzing health records from over 290,000 patients found no significant link between Semaglutide use and the risk of Recent Meta-Analysis Argues NAION Risk

Notably, 86.6% of participants lost at least 5% of their starting body weight by the end of the trial

Sources: Mayo Clinic: Semaglutide (Subcutaneous Route) Wegovy: Starting Wegovy Pill Diabetes Care: Gradual Titration of Semaglutide Results in Better Tolerability Ozempic: Dosing Information Wharton S, Freitas P, Hjelmesaeth J, et al

Diabetes (2015) 64(2):43446.10.2337/db14-0558 73 YeJHaoZMumphreyMBTownsendRLPattersonLMStylopoulosNet alGLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents

But free and safe

Patients should aim to drink water regularly rather than waiting until they feel thirsty, as thirst is often a late indicator of dehydration